ClinicalTrials.Veeva

Menu

Genetic- and Biological-Markers of Predisposition to Atherosclerosis: Leipzig-Heart Study (LE-Heart)

U

University of Leipzig

Status

Unknown

Conditions

Coronary Arteriosclerosis
Genetic Predisposition to Disease
Biological Markers
Atherosclerosis
Carotid Artery Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT00497887
276-2005

Details and patient eligibility

About

Atherosclerotic cardiovascular disease is the major cause of morbidity and mortality in Western societies. It is a complex genetic disorder with many genes involved and significant gene-environment interactions. The aim of the study is to identify novel genetic- and biological-markers of atherosclerosis. Atherosclerosis is assessed in the coronary arteries using coronary angiography as well as in the carotid artery (intima-media-thickness) and peripheral vessels (ankle brachial index). Association analysis of genetic and metabolic markers with atherosclerotic burden will be performed to identify novel factors of disposition to atherosclerotic vascular disease.

Enrollment

4,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients assigned to coronary angiography

Exclusion criteria

  • Cancer
  • Acute myocardial infarction
  • Inability to give informed consent

Trial contacts and locations

2

Loading...

Central trial contact

Gerhard Schuler, MD PhD; Joachim Thiery, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems